KO
KOAN.US Textmunication Holdings Inc
- Market cap
- USD 69.3K
- P/E
- -
- P/B
- 45.60x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.
Is KOAN.US undervalued?
Graham numberThe Graham number of Textmunication Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Textmunication Holdings Inc fundamental analysis
No fundamental analysis for Textmunication Holdings Inc yet.
Textmunication Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Textmunication Holdings Inc
Resonate Blends, Inc. engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine. It focuses on marketing licensed patent-pending natural stem cell mobilizing agents for enhancing individual's ability to mobilize their own adult stem cells from their bone marrow. The company also has a license to market a dual acting all-natural diet aid to help control hunger through normal body signals to the brain and stomach. In add…
Full company profileTextmunication Holdings Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Textmunication Holdings Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 458K | 944K | 1.07M | 1.05M | 0.00 | 27.0K | 49.5K | 16.5K | 1.90M | 1.70M | 969K |
| Gross Profit | 355K | 626K | 752K | 657K | 0.00 | 7.88K | 16.4K | -97.7K | 1.24M | 1.33M | 668K |
| Operating Income | -816K | -6.55M | -307K | -3.32M | -1.81M | -2.53M | -1.39M | -399K | -1.70M | -985K | -1.09M |
| EBITDA | -2.57M | -7.36M | -307K | -3.30M | -1.79M | -4.48M | 811K | -610K | -1.78M | -981K | -1.10M |
| Net Income | -3.26M | -7.65M | 21.0K | -3.88M | -2.05M | -5.02M | 2.87M | -1.42M | -2.13M | -1.73M | -3.87M |
| EPS | -25 | -3.83 | 0.00 | -0.35 | -0.08 | -0.16 | 0.04 | -0.02 | -0.02 | -0.01 | -0.01 |
| Balance Sheet | |||||||||||
| Total Assets | 458K | 511K | 534K | 131K | 169K | 301K | 399K | 992K | 1.85M | 2.36M | 2.56M |
| Total Liabilities | 1.64M | 984K | 257K | 718K | 1.17M | 4.40M | 1.55M | 3.13M | 5.05M | 7.06M | 8.19M |
| Shareholders' Equity | -1.18M | -473K | 277K | -587K | -996K | -4.10M | -1.15M | -2.14M | -3.20M | -4.70M | -5.62M |
| Cash & Short-term Investments | 0.00 | 10.2K | 68.5K | 53.1K | 114K | 12.9K | 64.4K | 6.94K | 8.05K | 41.0K | 217K |
| Total Debt | 571K | 184K | 31.8K | 173K | 692K | 1.91M | 989K | 2.45M | 3.86M | 5.30M | 5.92M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -433K | -146K | -102K | -809K | -1.38M | -2.79M | -1.43M | 11.2K | -1.03M | -1.52M | -1.21M |
| Capital Expenditure | 0.00 | 45.2K | 36.0K | 36.0K | 36.0K | 36.0K | 0.00 | 805K | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -433K | -191K | -102K | -809K | -1.38M | -2.83M | -1.43M | 11.2K | -1.03M | -1.52M | -1.21M |
| Ratios | |||||||||||
| ROE | - | - | 7.6% | - | - | - | - | - | - | - | - |
| ROA | -712.0% | -1,498.2% | 3.9% | -2,968.2% | -1,214.2% | -1,667.9% | 718.7% | -142.7% | -115.0% | -73.3% | -150.9% |
| Net Profit Margin | -711.8% | -810.5% | 2.0% | -369.5% | - | -18,569.9% | 5,794.6% | -8,598.4% | -112.5% | -101.7% | -399.0% |
| Debt to Equity | - | - | 0.11x | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Textmunication Holdings Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Apr 10, 1996
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | USD 468K | 0.04 | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:1000 on Jul 9, 2018.
Who owns Textmunication Holdings Inc
- Insiders 1.50%
- Institutions 0.00%
- Public & others 98.50%
- Shares outstanding 346M
- Free float 192M
Textmunication Holdings Inc company profile
- Company name
- Textmunication Holdings Inc
- Ticker
- KOAN.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- One Marine Plaza, North Bergen, NJ, United States, 04047
- Phone
- 786 369 9696
- Website
- apollobiowellness.com
About Textmunication Holdings Inc
Resonate Blends, Inc. engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine. It focuses on marketing licensed patent-pending natural stem cell mobilizing agents for enhancing individual's ability to mobilize their own adult stem cells from their bone marrow. The company also has a license to market a dual acting all-natural diet aid to help control hunger through normal body signals to the brain and stomach. In addition, it is involved in the research and development activities focusing on exploring other areas, such as Secretogues to enhance a person's own growth hormone production and similar natural bioactive formulations to enhance human performance utilizing known body mechanisms without the use of drugs. The company is based in North Bergen, New Jersey.
Textmunication Holdings Inc management
6- Mr. James W. ZimblerPresident, CEO, CFO, Principal Accounting Officer, Secretary & Director · born 1961
- Mr. Nick Allen MinielloCo-Founder & Former VP of Sales · born 1980
- Mr. Ambadas KshirsagarVice President of Technology
- Gaynell RogersAdvisor
- Bert RichardsAdvisor
- Mr. Adam WilksAdvisor · born 1986